Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2007 1
2008 2
2010 3
2011 2
2012 2
2016 1
2018 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
MAGE-A antigens as targets for cancer immunotherapy.
Schooten E, Di Maggio A, van Bergen En Henegouwen PMP, Kijanka MM. Schooten E, et al. Cancer Treat Rev. 2018 Jun;67:54-62. doi: 10.1016/j.ctrv.2018.04.009. Epub 2018 Apr 26. Cancer Treat Rev. 2018. PMID: 29763778 Review.
Adenovirus-derived vectors for prostate cancer gene therapy.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC; GIANT Consortium; Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G. de Vrij J, et al. Among authors: schooten e. Hum Gene Ther. 2010 Jul;21(7):795-805. doi: 10.1089/hum.2009.203. Hum Gene Ther. 2010. PMID: 19947826 Review.
Clinical adenoviral gene therapy for prostate cancer.
Schenk E, Essand M, Bangma CH; GIANT FP6 Consortium; Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Danielsson A, Dautzenberg IJ, Dzojic H, Erbacher P, Fisher K, Frazier A, Georgopoulos LJ, Hoeben R, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Lindholm L, Magnusson M, Maitland N, Neuberg P, Nilsson B, Ogris M, Remy JS, Scaife M, Schooten E, Seymour L, Totterman T, Uil TG, Ulbrich K, Veldhoven-Zweistra JL, de Vrij J, van Weerden W, Wagner E, Willemsen R. Schenk E, et al. Among authors: schooten e. Hum Gene Ther. 2010 Jul;21(7):807-13. doi: 10.1089/hum.2009.206. Hum Gene Ther. 2010. PMID: 20001452 Review.
Chimeric antigen receptors for T-cell based therapy.
Cheadle EJ, Sheard V, Hombach AA, Chmielewski M, Riet T, Berrevoets C, Schooten E, Lamers C, Abken H, Debets R, Gilham DE. Cheadle EJ, et al. Among authors: schooten e. Methods Mol Biol. 2012;907:645-66. doi: 10.1007/978-1-61779-974-7_36. Methods Mol Biol. 2012. PMID: 22907378
Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC, Boom DR, Klous P, Schooten E, Marquez VE, Wierda RJ, Holling TM, van den Elsen PJ. van Eggermond MC, et al. Among authors: schooten e. Biochem Pharmacol. 2011 Nov 15;82(10):1430-7. doi: 10.1016/j.bcp.2011.05.026. Epub 2011 Jun 2. Biochem Pharmacol. 2011. PMID: 21664896
17 results